Hyperphosphatemia Clinical Trials

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

Dose-finding Study of MCI-196

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol (ECRIP)

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study (LANDMARK)

A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease

The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

Sevelamer Hydrochloride in Peritoneal Dialysis Patients